AstraZeneca to acquire cancer therapeutics firm TeneoTwo
The British drugmaker will acquire all the outstanding equity in TeneoTwo, along with its clinical-stage cancer therapy candidate…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Jul 22
The British drugmaker will acquire all the outstanding equity in TeneoTwo, along with its clinical-stage cancer therapy candidate…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Jul 22
The company’s claim was based on more than two decades of work on mRNA technology, which played a…
05 Jul 22
WuXi Biologics said the expansion is in response to growing market demand and will enable it to provide…
04 Jul 22
Under the new agreement, Oxford Biomedica will manufacture AstraZeneca’s Covid-19 vaccines at its 84,000ft² manufacturing facility in Oxbox,…
04 Jul 22
The company is entitled to receive a settlement fee of $55m and will assume responsibility for the marketing…
01 Jul 22
The financing from two life science-focused investors is expected to provide capital to expand Blueprint’s pipeline towards commercialisation…
01 Jul 22
The US FDA has paused new enrolment in the US and told the participants who have been enrolled…
30 Jun 22
With the new investment, Fujifilm will add eight new 20,000L bioreactors at FDB’s manufacturing site in Hillerød, Denmark,…
30 Jun 22
Under the terms of the deal, the companies will supply 105 million doses of their Omicron-adapted Covid-19 vaccines,…
29 Jun 22
The European regulator approved Nexviadyme to treat the full spectrum of Pompe disease and Xenpozyme to treat non-Central…